(Il Sole 24 Ore Radiocor) - Milano, 4 mag - In Brussels trade, shares of the Belgian biopharma firm UCB fell 1.00% to 227.50 euros as investors reacted coldly to the announcement of a definitive agreement to acquire Candid Therapeutics, a US biotech company specialized in autoimmune disease treatments.

In Frankfurt, automotive stocks moved into reverse after US president Donald Trump announced plans to hike customs duties on EU cars and trucks to 25%, sending Mercedes-Benz down 1.70% to 48.74 euros and BMW 1.69% lower to 76.60 euros.

In Milan, Prysmian remained under the spotlight, gaining 1.06% to 129.30 euros as the market continued to cheer its first quarter 2026 financial results.

Meanwhile, in Paris, Soitec shares soared 15.40% to 146.50 euros, boosted by positive ratings and an upbeat outlook from.

analysts at Deutsche Bank.

(RADIOCOR) 04-05-26 11:57:33 (0241) 5 NNNN